mailtimers.com

LabUniversity is a medical laboratory education organization that uses a unique approach to guide laboratories of all sizes: interactive education. At the Symposium for Clinical Laboratories, attendees participate in EDUCATION FOR LABORATORY EXCELLENCE – making a positive impact on quality patient care.

Participants can attend a wide selection of educational sessions, earn P.A.C.E® credits, network with healthcare professionals and visit the exhibit hall featuring the latest laboratory technology, equipment, and supplies.

Who Attends Symposium

      • Physicians
      • Laboratory Directors
      • Laboratory Technical Consultants
      • Laboratory Technologists and Technicians
      • Laboratory Managers
      • Testing Personnel
      • Other Healthcare professionals

The Symposium is YOUR opportunity to meet personal, professional, and organizational goals at a reasonable cost. We have designed the curriculum for continuing education that’s critical to operating a successful and compliant medical diagnostic laboratory. The educational sessions will offer:

  • Continuing education for lab staff to enhance competency and maintain state licensure
  • Tools and guidance for:
    • Meeting the requirements of CLIA, and other accrediting organizations
    • Improving laboratory processes and procedures
    • Preventing laboratory errors
    • Improving efficiency and promoting quality in laboratory operations

The Symposium for Clinical Laboratories includes Keynote General Sessions of broad interest, and a choice of breakout sessions addressing various needs and interests. Subject content presented includes but is not limited to the following:

    • Clinical testing topics
    • Quality Control
    • Quality management and improvement
    • Safety and Phlebotomy 
    • Regulatory compliance
    • Laboratory management and operations
    • Inspection Preparation

LabU is approved as a provider of continuing education programs in the clinical laboratory sciences by:

    • The ASCLS P.A.C.E.® Program. P.A.C.E.® continuing education credits are accepted by all states with continuing education requirements for laboratory personnel licensure
    • The Board of Clinical Laboratory Personnel, Division of Medical Quality Assurance at the Florida Agency for Health Care Administration
    • The California Division of Laboratory Science, Department of Laboratory Field Services

Register Now

Symposium for Clinical Laboratories returns with another exciting lineup of educational sessions, speakers, and exhibitors. Registration is now open for this premier, in-person event hosted by LabU.

GRAND HYATT SAN ANTONIO
600 E. Market Street
San Antonio, Texas 78205

We have secured a special nightly rate of $175, plus taxes and fees, for all Symposium attendees.

The hotel room block special rate deadline has been extended to May 9.

hotel-img

Grand Hyatt San Antonio sits in the heart of historic downtown along the famed River Walk. For convenient arrivals and departures, San Antonio International Airport (SAT) is only nine miles away and the San Antonio Station is a quick jaunt from the hotel.

Grand Hyatt San Antonio celebrated its 10th anniversary in March 2018 with the completion of a $19 million renovation of guestrooms, meeting spaces, bar, corridors and lobby. Located along the San Antonio River Walk and next to the Henry B. González Convention Center, the hotel offers 1,003 guestrooms including 46 suites, all with new Hyatt Grand beds and 55-inch flat-screen televisions. Newly-installed plush indigo carpeting, ivory wall coverings and warm wooden tones of teak and birch reflect San Antonio’s lush landscape. In the lobby, visitors are greeted by exquisite wall coverings, Italian tile and marble and stylish furniture with easily accessible electric outlets. Grand Hyatt San Antonio’s 115,000 square feet of indoor and outdoor meeting space also received stylish upgrades and have been modernized as well.

Grand Hyatt San Antonio offers three outstanding dining experiences designed to please your palate Texas-style. Whether it’s a taste for hearty prime rib steak or a grab-and-go sandwich, and anything else in between, Grand Hyatt San Antonio has an option for you—including room service.

To make a reservation by phone, please call (210) 224-1234.
Reference the program name LabU Symposium for Clinical Laboratories or give the group code G-E9DI and the dates of June 1-3, 2022.

Thursday, June 2, 2022

7:30 – 8:30

Exhibits Open, Breakfast

8:30 – Noon

Opening General Sessions 

8:30 – 9:00

Welcome, Introduction and Opening Remarks

9:00 – 10:00

Keynote: CMS CLIA Update 2022
Daniel Hesselgesser, MT(ASCP), CLIA Manager for the Texas Region

ASCLS P.A.C.E.® credits: 1.0

This session will provide an update on current CMS activities related to the CLIA program. Specific topics will be included as CMS activities evolve between now and the meeting date.

Learning Objectives

  • Outline current CMS activities that impact laboratories
  • Summarize the overall CMS enrollment data for laboratories and the various certificate types in each category

10:00 – 10:30

Exhibits Open, Break

10:30 – Noon

Creating and Sustaining a Leading Laboratory
Diana Kremitske, MHA, MS, MT(ASCP) and Barbara Caldwell, MS, MASCP, MLS(ASCP)CMSHCM

ASCLS P.A.C.E.® credits: 1.5

Leading laboratories make quality and patient-centric improvement their primary commitment. And their leaders foster trust-based professional relationships through open communication.

Investment in the laboratory’s multidisciplinary teams can enhance their technical and leadership skills to drive peak performance on behalf of patients. Through professional development, team members enhance their skillsets to elevate innovation and help their organizations thrive. This session  emphasizes the value of the laboratory leader’s engagement in highlighting the laboratory’s importance in the lives of patients and the community.

A case study will explore how Geisinger Medical Center employs leading laboratory practices for superior performance from laboratory team members at all levels.

Learning Objectives:

  • Explore how leading laboratories demonstrate a focus on strategic partnerships with multidisciplinary health care team members for quality patient outcomes.
  • Recognize the importance of creating laboratory visibility and communicating the impact of the laboratory team on patient care.
  • Consider the importance of “trusted leadership” to the success of the laboratory and the actions that leaders must take to gain trust from patients, clinical partners, and the community.
  • Identify professional development requirements and opportunities to keep members of the laboratory team competitive in a technologically advancing market.
  • Review a case study example of a leading laboratory in action.

Noon – 1:00

Lunch

12:30 – 1:30

Exhibits open (with dessert!)

1:30 – 3:00

Afternoon Breakout Session A
(Select one. Each session earns 1.5 ASCLS P.A.C.E.® credits)

A01 Technology Workshop: Chemistry Instruments
participating exhibitors

Assess general chemistry and immunoassay analyzers that may be suitable for your practice. The instrumentation shown will be appropriate for a small to moderate patient testing volume. Handouts include guidelines for instrument selection. Small groups will have time with each instrument.

Learning Objectives

      • Identify factors to consider when selecting a chemistry instrument.
      • Recognize potential pitfalls in the selection process.
      • Analyze the differences between systems to determine which would be the most appropriate for a particular lab setting.

A02 “All Hands on Deck” Today’s POCT Programs Require Teamwork
Kim Futrell, MT(ASCP), MSHI

The diversity found in point-of-care testing (POCT) makes its implementation and oversight complex. One of the greatest challenges is training and managing disparate groups of healthcare workers as end users. Approaching POCT oversight with a multidisciplinary approach can improve the quality of the POCT program and the relationships between departments. Considering the viewpoints of end users and assessing workflow where POCT is introduced can set the stage for a successful program that is integral to improving patient outcomes.

Learning Objectives

      • Relate recent changes in healthcare to continued growth of POCT.
      • Describe opportunities for the laboratory to collaborate with other departments for quality POCT.
      • Contrast differences in perspective between nursing and laboratory departments as it pertains to POCT.
      • Recommend ways to improve the laboratory/end user relationship in POCT.

A03 How to Conduct an Audit and Root Cause Analysis: We Are Still Learning
Donna Castellone, MS, MASCP, MT (ASCP) SH

Auditing can uncover a break in the testing process. They can ensure appropriate processes in quality-management systems. A ‘quick-hit’ audit can be vital in documenting the most common laboratory deficiencies. And since COVID has become part of the daily work environment, it is more important than ever that audits are purposeful, concise, and focused.

Despite their importance, audits can result in more questions than answers. Conducting a systematic analysis can help to uncover the root cause of a problem. Rerunning a specimen is not root-cause analysis. Best practices will be covered in this session, as well as tips for minimizing the time invested in performing these tasks and maximizing results.

Learning Objectives:

      • Identify the advantages of conducting purposeful audits.
      • Describe how to conduct systematic root-cause analysis.
      • Enhance problem solving skills relating to case studies.

A04 Introduction to Laboratory Regulations, Point-of-Care Testing Management (Including Determining Which Tests Compliment Your Program)
Jeanne Mumford, MT(ASCP)

This session begins with an overview of CLIA testing certificates and regulation requirements. It will include examples of waived and non-waived tests, including provider performed microscopy. It will cover managing these tests and defining the roles and responsibilities of all staff required to manage a point-of-care team.

This session will wrap up with an overview of how to evaluate, review, and approve a new point-of-care test including a summary of how to establish an interface with your electronic patient medical record.

A05 CMU Covid Testing Project
Florent Letronne, PhD, Milly Keeler, BSMT(ASCP), CLC(AMT)

Presenters will share their experience working with the Carnegie Mellon University Tartan Testing Lab Team on the COVID-19 response. Hear how CMU scaled up for saliva testing in a few months using two autosampler robots, three qPCR instruments, and a custom LIS workflow designed by CMU’s IT department. Learn about the challenges—hiring the right laboratory personnel, completing validation studies, dealing with supply issues, and varying test volumes—and about ongoing efforts to find improvement.

Learning Objectives:

      • Define and describe some of the common challenges when starting or scaling up laboratory testing.
      • Recognize the collaboration of a diverse team required to accomplish a project such as this.
      • Gain ideas from others to improve laboratory testing for positive patient outcomes.

A06 Professionalism, Professional Identity and Patient Care
Catherine Otto, PhD, MBA, MLS(ASCP)CM

As healthcare practitioners, how we view ourselves in our roles in the health care delivery system is vital to quality patient care. Learn the difference between professionalism and professional identity, the process of developing professional identity, and how to enhance professional identity in the workplace.

Learning Objectives:

      • Distinguish among profession, professionalism and professional identity.
      • Understand the relationship between one’s professional duty to patients and one’s self-image as a professional.
      • List strategies professionals and managers can use to enhance the professional identity of staff members

3:00 – 3:30

Exhibits open, beverage break 

3:30 – 5:00

Afternoon Breakout Session B
(Select one. Each session earns 1.5 ASCLS P.A.C.E.® credits)

B11 Technology Workshop: Laboratory Information Systems
participating exhibitors

Compare and evaluate multiple laboratory information systems (LIS). Small groups will allow for questions and discussion. This is an important session whether you are already using an LIS or are evaluating what is available and best suited for your laboratory.

Learning Objectives

      • Understand functions for computers in the lab (e.g., instrument data acquisition, billing, appointment management, tracking of referred specimens, record keeping).
      • Identify desirable features in a computer system and how to ask questions.
      • Analyze the differences between systems to determine which LIS would be the most appropriate for a particular lab setting.

B12 Best Practices to Avoid a Potential Lawsuit in Phlebotomy
Kathleen Finnegan, MS, MT(ASCP)SH

Phlebotomy is an invasive procedure and healthcare workers who collect blood can and will be held legally accountable for their skills. This presentation will review guidelines to avoid lawsuits, describe situations and cases that may have legal ramifications, and discuss best practices to avoid legal action associated with phlebotomy procedures.

Learning Objectives

      • Review best practices in phlebotomy for quality specimens.
      • Discuss the CLSI standard of care and the guidelines to follow.
      • Describe the type of phlebotomy errors that can lead to a lawsuit.

B13 Laboratory Billing and Coding (3:30-5:30, 2.0 P.A.C.E.® credits)
Shannon O. DeConda, CPC, CEMC, CEMA, CPMA, CRTT

This extended session covers coding concerns for lab-based services with a review of CPT, ICD-10, and modifier usage. We will then focus on potential bundling edits and medical policies that can impact revenues for the physician-based lab. The fast-paced session will cover and array of issues to provide a great review for the seasoned professional and great training for those new to coding/billing.

Learning Objectives:

      • Review CPT, ICD-10, and modifier usage, and lab coding concerns.
      • Outline bundling edits and medical policies that can impact lab revenue.

B14 Effective Quality Assessment
Irwin Rothenberg, MBA, MS, MT(ASCP)

Quality Assessment (QA) is a pro-active, continuous process of systemic reviews that monitor all phases of laboratory testing. It ensures that all standards of performance are met and that any deficiencies noted are addressed immediately. An effective QA plan identifies problems so as to avoid potentially negative impacts on your patients. Follow-up audits ensure that the corrective actions taken were effective. The Quality Assessment Plan details this process and defines roles and responsibilities. QA is a key component in creating a culture of quality for your laboratory.

Learning Objectives

      • Define QA and differentiate it from QC.
      • Summarize the objectives, components, and structure of a Quality Assessment Plans.
      • Implement your QA plan by performing QA reviews.
      • Comply with regulatory criteria that address Quality Assessment.
      • Apply the longer–term goal of creating a culture of quality.

B15 Panel Discussion: Covid-19 Lessons Learned
Milly Keeler, BSMT(ASCP), CLC(AMT), moderator

This session is an interactive discussion of the role of the laboratory in the COVID-19 response. Panel members include lab colleagues and regulatory agencies (CMS, CDC). Discussion will focus on the biggest challenges faced and solutions/resources used; what panelists wish they had known at the beginning of the pandemic; what keeps them up at night even now; what have we learned to better prepare for the next pandemic.

Learning Objectives:

      • Discuss common challenges that are causing stress in the laboratory response to COVID-19.
      • Discover how others are addressing these problems.
      • Identify potential solutions/resources that can support positive outcomes in your laboratory.

B16 Most Frequently-Cited Laboratory Standards
Ann Cortés, MT(ASCP)

Laboratories are among the most highly regulated areas in healthcare. In order to improve quality and performance, this session will highlight the most frequently cited laboratory standards to help laboratory staff understand these standards and analyze their own laboratory’s practices.

To provide usable knowledge to take back to the office, the session will include tips for compliance with challenging standards and discuss implementation methods to prevent future deficiencies in the laboratory.

Learning Objectives

      • Identify the most frequently cited laboratory standards in 2020-2021
      • Understand these standards to analyze their own laboratory’s practices
      • Describe tips to comply with these challenging standards
      • Implement methods to prevent deficiencies

5:30 – 7:30

Reception for participants, faculty, and exhibitors

  • Cocktails and heavy hors d’oeuvres

Friday, June 3, 2022

8:00 – 8:45

Exhibits Open, Breakfast

8:45 – 10:00

Day 2, General Sessions

8:45 – 8:50

Welcome, Housekeeping & logistics

8:50 – 10:00

Putting Patient Safety First: The Role of Laboratory Professionals in Laboratory Medicine
Catherine Otto, PhD, MBA, MLS(ASCP)CM

ASCLS P.A.C.E.® credits: 1.25

Laboratory test information plays a vital role in medical decisions that directly impacts patient health outcomes.  Laboratory testing services are provided in diverse settings, from waived testing physician office laboratories (POLs), pharmacies, home care, insurance screenings, wellness fairs to large physician office laboratories, independent laboratories, hospitals and healthcare systems.  Regardless the laboratory testing setting, patients expect and deserve to receive care that is safe, effective, efficient, timely, patient-centered and equitable.  It is time for us to step up, speak out and take action to put “Patient Safety First in Laboratory Medicine.”

Learning Objectives

  • Define patient safety as it relates to laboratory medicine using the six quality aims
  • List one method to improve patient safety for each of the six quality aims
  • Describe the role of the 5 healthcare professional competencies for improving patient safety

10:00 – 10:30

Exhibits Open

10:30 – Noon

Morning Breakout Session C
(Select one. Each session earns 1.5 ASCLS P.A.C.E.® credits)

C21 Reducing Human Error in POCT: Performance Improvement Monitoring for Enhanced Inspection Readiness
Jeanne Mumford, MT(ASCP)

This session includes strategies for inspection readiness with ideas and practices from CLIA and deemed accrediting organizations plus self-inspection techniques for any size point-of-care program. The session will include an interactive exercise where attendees will review case studies from actual audits and inspections and discuss their current tools and processes for inspection readiness. This session will wrap up with a discussion of choosing quality indicators. We’ll cover how to identify the need for a quality indicator, how to measure them, and how to monitor them through the use of a report card.

C22 Technical Consultant Responsibilities
Irwin Rothenberg, MBA, MS, MT(ASCP)

The ability of a laboratory to provide quality services cannot be achieved without the direct involvement of dedicated Technical Management. In a moderate complexity lab, this is the Technical Consultant (TC) and in a high complexity lab this is one or more Technical Supervisor (TS). These positions are required by CLIA and are important for the regulatory and operational success of the laboratory. This presentation will review the qualifications required for these roles.

Learning Objectives

      • Summarize the qualifications and responsibilities of the Technical Management positions.
      • List examples of how these responsibilities are carried out.
      • Describe the relationship of the technical consultant/supervisor to other positions in the laboratory.

C23 Case Studies in Urinalysis
Kathleen Finnegan, MS, MT(ASCP)SH

Examine aspects of urinalysis by reviewing case studies. These case studies will be used to explain significant findings in urine for a variety of disorders.

Learning Objectives:

      • Correlate abnormal urinalysis results from the case studies.
      • Describe various diseases of the kidney.
      • Review the importance of microscopic findings in urinalysis.

C24 Who Knew? Where we were, Where we are, and Where we are going!
Donna Castellone, MS, MASCP, MT (ASCP) SH

Progress in technology and methods have transformed how we function in the laboratory. The journey from where we started out to where we are now is hard to imagine. Not only has the physical laboratory changed but regulations, training, and compliance issues have evolved into complicated processes in addition to performing laboratory testing. Many behind-the-scenes events have shaped laboratory medicine and will continue to impact how and why we test. A pandemic that placed the laboratory in the forefront of testing may have moved us out of the basement, but how far have we really come? This session will look at the past, present and future of laboratory medicine.

Learning Objectives:

      • Identify regulations in the laboratory, how they began, and where they stand today.
      • Understand the impact of quality outcomes and how physicians order tests and are reimbursed.
      • Evaluate what you can do to enhance your career in this environment.

C25 The Business of Running a Lab
Barry Craig

We sometimes forget that the laboratory can do more than provide answers for patient diagnosis. The lab should cover all costs associated with its operation and be a source of revenue for the practice or office.

The first part of the session will examine:

      • Test Menu: What tests are medically necessary and will not cause red flags?
      • Product Selection: How can I get the best price on analyzers and consumables?
      • Financial Feasibility: Are the tests I want to run going to be profitable?

The second part of the session will focus on improving the lab financially:

      • Increase Revenue – How can I boost revenue within the confines of my current testing?
      • Reduce Costs – What steps can I take to reduce costs for the lab and my practice in general?

C26 Standardizing Titles and the Doctorate in Clinical Laboratory Science
Elissa Passiment, Ed.M., MT(ASCP)

Laboratory professionals are critical contributors to the science of medicine, enabling everyone on the health care team to provide quality care. Our role is crucial for quality diagnoses, treatment, and patient safety. However, there is a persistent lack of recognition by the public and our colleagues on the healthcare team. One of the contributing factors is the lack of a consistent identity/name/title for the practitioners in our profession.

This session covers the history and challenges of that identity struggle and the efforts of the ASCLS, ASCP, and other organizations to standardize titles and educational requirements for our profession and advance the practice with the doctorate in clinical laboratory science (DCLS).

Also covered are the requirements of patient access to laboratory reports, patient safety emphasis, and the implications of scientific advancement on the practice of laboratory science that will change our approach to delivering services.

Learning Objectives:

      • Describe the history of the educational requirements and titles of practitioners in the laboratory science profession.
      • Discuss the impact of multiple names and educational routes on the profession.
      • Evaluate the latest standardization of titles.
      • Analyze the applications of the DCLS on patient care.

Noon – 1:00

Lunch

1:00 – 2:30

Afternoon Breakout Session D
(Select one. Each session earns 1.5 ASCLS P.A.C.E.® credits)

D31 Competency Assessment: How, Who, What, When and Why?
Donna Castellone, MS, MASCP, MT (ASCP) SH

Competency assessment is a complicated process. The goal of this session is to provide participants with information to minimize the complexity and time invested to complete this directive. The difference between training and competency will be discussed as well as who can perform these tasks. All elements of competency will be reviewed. Integrating competency assessment into routine work can eliminate some of the tedious processes.  Case studies will be used to encourage audience participation in solving common problems that occur during competency assessment.

Learning Objectives

      • Define competency.
      • Explain difference between training and competency.
      • List the elements required for competency assessment.
      • Discuss who can perform competency assessments.

D32 Considerations for Urine Drug Testing
Barry Craig

Drug testing has become a necessity in our society. Abuse of opioids, OTC medications, and the usual illicit drugs has reached epidemic proportions. Pain management, orthopedics, drug rehabilitation facilities, and even rural health facilities need this testing to properly prescribe medications and check for abuse.

This session will examine considerations when adding qualitative drug testing to your menu:

      • Function of screening testing
      • Frequency of testing
      • Coding for qualitative testing
      • When to confirm with a reference lab
      • Qualitative vs. semi-quantitative
      • Clinical toxicology vs. forensic toxicology
      • Validity testing with screening methods
      • Test selection
      • Quality Assessment program
      • Quality Control program
      • Proficiency Testing
      • Start Up validations

D33 Case Studies in Hematology
Kathleen Finnegan, MS MT(ASCP)SH

Case studies will be used to explain significant findings for a variety of hematologic disorders, including anemia, acute and chronic leukemia, myeloproliferative disorders and myelodysplastic syndromes.

Learning Objectives:

      • Correlate peripheral blood smear findings with hematologic data.
      • Identify diagnostic criteria used in characterizing each of the disease states.
      • Review abnormal WBC and RBC morphology.

D34 Federal Government: Critical Laboratory Issues and Updates on Laboratory Reimbursement and Other Regulatory Issues
Elissa Passiment, Ed.M., MT(ASCP)

CLIA regulations, FDA concerns about Laboratory Developed Tests, and CMS PAMA reimbursement cuts have been actively impacting the clinical laboratory for a number of years. This session addresses the latest from these agencies, efforts to once again postpone the PAMA cuts, the personnel shortage, new reimbursement models proposed by CMS, the controversy surrounding FDA laboratory developed test guidance and efforts to thwart oversight, and the status of CLIA activities.

Learning Objectives:

      • Describe the areas addressed in current health care reform efforts.
      • Analyze the implications of the CMS PAMA and FDA efforts on clinical laboratory services and business.
      • Evaluate the pending changes in PT requirements under CLIA.

D35 Effective Test Utilization: Enhancing Laboratory Stewardship though Implementation of Choosing Wisely Recommendations
Barbara Caldwell, MS, MASCP, MLS(ASCP)CMSHCM

The Choosing Wisely (CW) campaign was launched in 2012 by the American Board of Internal Medicine (ABIM) Foundation. ASCP joined with more than 80 specialty society partners to put forth recommendations to facilitate decisions by patients and providers about appropriate care and utilization of medical services. This educational session will explore the ASCP CW laboratory recommendations to date, the new ASCP COVID-19 recommendations, and the non-ASCP CW laboratory-related recommendations. The results of two different surveys will be discussed: 1) an ASCP survey designed to capture the relevance and priority of CW recommendations to pathologists, laboratory professionals, and what laboratory-related topics are most important to other medical societies; 2) an ASCP survey to study the engagement of laboratories across the US in implementing CW recommendations into practice. The ASCP 2021 Choosing Wisely champions will be highlighted.

Learning Objectives:

      • Describe the ABIM Foundation Choosing Wisely (CW) national initiative.
      • Discuss ASCP Laboratory CW recommendations.
      • Present new 2022 ASCP’s COVID-19 recommendations.
      • Review non-ASCP CW recommendations relevant to pathology and laboratory medicine.
      • Relate results of recent ASCP Choosing Wisely Engagement Survey.
      • Announce ASCP 2021 Choosing Wisely Champions.
      • Participate in a brief, interactive session to discuss how often, in what types of facilities, and what areas of the laboratory CW recommendations have been implemented

2:30 – 3:30

Exhibits Ice Cream Social and Exhibits in the Exhibit Ballroom

3:30 – 5:30

Afternoon General Sessions

3:30 – 4:30

Strategies for Advancing Biosafety in Clinical Laboratories
Reynolds Salerno, PhD, Director of the Division of Laboratory Systems, Centers for Disease Control and Prevention

1.0 P.A.C.E. credits

Ensuring that laboratory personnel can safely perform testing with all types of patient specimens is critically important for laboratory directors, managers, supervisors, and testing personnel. There are biosafety risks associated with specimens tested for infectious agents and specimens that could potentially harbor pathogens. Dr. Reynolds Salerno, Director of the Division of Laboratory Systems (DLS), Centers for Disease Control and Prevention (CDC), will discuss the importance of ensuring biosafety for the environment as well as for personnel who work in all types of clinical laboratories and point-of-care testing sites. He will provide information on assessment tools for identifying and mitigating biosafety risks, and evaluating mitigation measures. He will also describe applicable safety regulations and biosafety guidelines and standards. Last, he will review DLS’ training resources related to laboratory biosafety, including those that offer free continuing education credits, and other DLS biosafety initiatives.

Learning Objectives:

  • Describe biosafety risks associated with specimens that could potentially harbor pathogens
  • Raise awareness of existing safety regulations and biosafety guidelines and standards
  • Understand how to apply bio-risk management systems and methods to address clinical laboratory biosafety
  • Explore available training resources

4:30 – 5:15

Glucose Meters and Regulatory Compliance:  Important Factors for Effective Use of POCT
William Clarke,
PhD, MBA, DABCC

.75 P.A.C.E. credits

This session will discuss important considerations for use of glucose meters, both analytically and in terms of regulatory compliance.  Additionally, the impact of current regulatory guidelines and the FDA guidance on POC glucose implementation will be discussed.

Learning Objectives:

  • List factors that can influence glucose meter performance
  • Discuss important factors for regulatory compliance
  • Describe the impact of the FDA guidance for glucose meters on workflow and operations in healthcare facilities

5:30

Symposium for Clinical Laboratories Adjourns

PRICING: 

8’ x 10’ Booth: $2,900
(Including registration for up to five representatives)

6’ Tabletop Only: $2,200
(Including registration for up to three representatives) 

EXHIBIT SPACE INCLUDES:

  • Draped and skirted 6’ table with two side chairs, a wastebasket, and signage
  • Symposium syllabus (on a flash drive)
  • Entrance to all educational sessions
  • Participant list
  • Evening reception, continental breakfasts, and meeting breaks 

TECHNOLOGY WORKSHOPS: 

For companies exhibiting Laboratory Information Systems or bench-top chemistry analyzers, sponsoring a LabU Technology Workshop is a valuable additional opportunity to educate attendees in a round-robin style demonstration. 

There is a $675 fee per workshop. You must be a paid exhibitor to participate in a workshop. 

Space is limited to six companies. Presentation time is based on the number of participating exhibitors with a minimum of 15 minutes if the workshop reaches sponsorship capacity.

SPONSORSHIP OPPORTUNITIES: 

Build on the enthusiasm around the LabU Symposium by becoming a sponsor. Gain additional exposure for your company in the clinical laboratory market. Sponsorship is available even if your company is unable to attend in person.

ATTENDEE TOTE BAGS $2,000 Fulfilled

Make your company’s logo one they remember well after the event.
Bags are provided to all participants and speakers. 

SYMPOSIUM SYLLABUS FLASH DRIVE $1,500 

Sponsor the frequently referenced resource containing all Symposium handouts. Your company’s name and logo will be featured on one side
of the flash drive. 

WELCOME RECEPTION $1,000 Fulfilled

At Thursday night’s reception, cocktail napkins and other signage
will show attendees that the drinks are on you!  

NAME BADGE LANYARDS $1,000 Fulfilled

All Symposium attendees will wear your company’s logo and
name around their necks and thank you for saving their shirts! 

EXHIBIT HALL DESSERT BREAK $750 

No one can pass up a dessert! The Dessert Break is served right after
lunch in the Exhibit Hall on Thursday, June 2, 2022.

ICE CREAM SOCIAL $750 

A Symposium favorite. Need we say more? 

WiFi  $1,000 

Provide Symposium attendees with complimentary WiFi access. Promote your brand on WiFi access points and signage through out the conference.

EXHIBITORS: 

Abbott
Accreditation Commission for Health Care
American Proficiency Institute
Athelas
AUDIT MicroControls, Inc.

Bio-Rad Laboratories
CompuGroup Medical
Henry Schein Medical Clinical Lab Team
LabLynx
Laboratory Management Consultants

Lighthouse Lab Services
Orchard Software Corporation
Randox
WSLH Proficiency Testing
ZC Lab Services

Please email Cynthia Cardelino at ccardelino@labu.org with any questions or inquiries.

On the cusp of the Hill Country, rooted on the banks of a spring-fed river, Latino, Western and European cultures mingle to form a city unlike any other—San Antonio. Walk amidst eighteenth-century missions; explore the River Walk with its sidewalk cafes, theaters, and shops; savor flavorful cuisines that outspread the label of ethnic, and join celebrations thrown at the drop of a sombrero.

Deep in the heart of Texas, San Antonio’s bold culture and historic legacies make it an ideal gateway to Latin American culture and so much more.

The rolling terrain of the Hill Country around San Antonio has drawn charming vineyards, hillside bed and breakfasts, and nationally acclaimed resorts that offer rustic refinement in the most pampering of ways, from championship golf courses to fireside spas and delectable restaurants. As you delve deeper into San Antonio, the essence of the city’s rich culture only grows stronger. Varied cuisines, including famed Tex-Mex, fill the air with rich aromas. Music flourishes: country-western bands, mariachis, folk singers, conjunto—all singing the songs of the city. Art comes alive with river gardens, Spanish colonial architecture, and prestigious museums. But nothing embodies the essence of San Antonio more than the people with their intimate and welcoming nature.

The flourishing River Walk cradles much of San Antonio’s unparalleled charm. Here you’ll find miles of meandering paths along the banks of the San Antonio River connecting hotels, restaurants, shops, historic landmarks and more.

It was this river that originally inspired the settlement of San Antonio, and it still flourishes today as the city’s center.

San Antonio is one of America’s most authentic and passionate cities, spirited with poets and lyricists, painters and sculptors, a city both rich and humble. Become a part of the living mural—and let San Antonio become a part of your heart.

Tex-Next: San Antonio Cuisine

Beyond the famous River Walk and the historic walls of the Alamo, San Antonio has a burgeoning culinary scene worthy of every palate. From the city’s unique blend of cultures sprout dishes that are rich in tradition and brimming with innovation. We call it “Tex-Next.” The city is on the fast-track to becoming one of the most celebrated dining destinations in the country. On the world stage, it was designated a UNESCO City of Gastronomy in November 2017.

Authentic Tex-Mex is a must for any trip to San Antonio. The cuisine is ever-present throughout restaurant and family cocinas, yet San Antonio extends well beyond the enchilada. Generational recipes are still being passed down while innovative dishes are popping up with speed and passion.

San Antonio and the surrounding Hill Country, an agriculturally rich area, seduce local chefs into becoming foragers. The dining scene is abundant with wild game, locally grown produce and even chiles found only in this region. To complement, the neighboring Texas Wine Trail in the Hill Country is one of the nation’s hottest wine destinations.

As a Gateway to Latin America, San Antonio is uniquely positioned to showcase and celebrate the richness of this cuisine. The third campus of the prestigious Culinary Institute of America (CIA) is located in San Antonio. Dedicated to the foundations of culinary instruction as well as specializations in Latin cuisine, this campus takes advantage of San Antonio’s cultural influences and access to indigenous ingredients. The school’s new full-service restaurant, SAVOR, opened January 2019 at Pearl and features Modern-American cuisine based on the CIA’s curriculum.

The CIA campus is located at Pearl, a food haven and shopping destination. San Antonio is an old brew town that has breathed new life into this well-known brewery in the heart of the city. A cluster of diverse restaurants offers some of the city’s best cuisine—from Central Texas barbecue and on-site brews at The Granary to Botika, where Asian-Peruvian fusion shines, to La Gloria’s street foods of Mexico. Pearl also offers a weekend farmers’ market where locals and chefs alike can gather the region’s bounty. Hotel Emma is a historic riverfront luxury boutique hotel at Pearl, combining the culture, history, and authenticity of the city.

LabU’s Symposium for Clinical Laboratories is presented with partnering sponsor, ACHCU. We jointly support vaccination, wearing masks, and social distancing as the best current means of mitigating the risk of contracting COVID-19.

The safety of our Symposium attendees, exhibitors, and speakers is important. Please take appropriate precautions to protect yourself and others and do not attend events if you are feeling unwell.

For more information, visit the Texas Department of State Health Services COVID-19 webpage.

Barbara Caldwell, MS, MASCP, MLS(ASCP)CMSHCM

Barbara Caldwell became an independent medical laboratory scientist consultant following 18 years as administrative director of clinical laboratory services at MedStar Montgomery Medical Center in Maryland.

Ms. Caldwell has taught hematology, immunohematology, molecular diagnostics, laboratory medicine, urinalysis, and laboratory management courses at the University of Maryland School of Medicine, Department of Medical and Research Technology (DMRT) where she received a number of excellence in teaching and student recognition awards.

She is the author of chapters on acute leukemias and myeloproliferative disorders in several hematology texts.

Donna D. Castellone, MS, MASCP, MT(ASCP)SH

Donna Castellone is a laboratory consultant, a clinical assistant at Columbia Medical Center, and an adjunct professor at Rutgers University with over 37 years of laboratory experience, including clinical trials.

Ms. Castellone writes a monthly blog for ANIARA Coagulation Corner and has contributed chapters to books, articles for publication, and presented many lectures on coagulation to diverse audiences at all levels of expertise.

William Clarke, PhD, MBA, DABCC

William Clarke is a professor in the Department of Pathology at Johns Hopkins University. He is the vice chair of pathology for quality and regulatory affairs and director of both point-of-care testing and clinical toxicology for the hospital. His research interests include clinical mass spectrometry, method development and evaluation for therapeutic drug monitoring, clinical toxicology, point-of-care testing, and development/validation of biomarkers for use in drug management.

Dr. Clarke has published as author or co-author over 160 peer-reviewed manuscripts or book chapters, is co-editor of the textbook Contemporary Practice in Clinical Chemistry, and co-editor-in-chief of the journal, Practical Laboratory Medicine.

Barry Craig

Barry Craig is a laboratory consultant with more than 25 years’ experience as a generalist, QA coordinator and microbiology supervisor. He served as lab coordinator for Children’s Hospital of Alabama for 12 years.

As the owner of Laboratory Consulting, LLC, Mr. Craig has extensive experience in regulatory compliance. He has started more than 200 moderate- and high-complexity laboratories in the last 15 years.

He is a contributor for several trade publications including MLO, ADVANCE for Administrators of the Laboratory, and Physician Office Resource.

Shannon O. DeConda, CPC, CEMC, CEMA, CPMA, CRTT

Shannon DeConda’s diverse experience in healthcare includes working in a physician practice, providing healthcare as a respiratory therapist, work in billing and coding, and currently, providing medical audit investigations and educating others in this process.

Ms. DeConda founded the National Alliance of Medical Auditing Specialists (NAMAS) to provide training, education, and resources for coders, auditors, and compliance professionals. She also established the Certified Professional Medical Auditor (CMPA) credential and began a grassroots effort to educate and certify these professionals.

Kathleen Finnegan MS MT(ASCP)SH

Kathleen Finnegan is clinical associate professor in clinical laboratory sciences at Stony Brook University of New York. Her clinical experience was focused at a small community hospital and she has 30 years of teaching in the disciplines of hematology, coagulation and phlebotomy.

Among many published articles and case studies in laboratory journals, Ms. Finnegan has published extensively and contributed chapters to multiple hematology texts.

A sought-after speaker at the local, state, national and international level, Professor Finnegan has had extensive experience teaching phlebotomy in African nations including South Africa, Swaziland, and Lesotho, with learning units prepared for Rwanda and Tanzania.

Tony F. Freeman, HT(ASCP)

Tony Freeman is a Laboratory Specialist with Accreditation Commission for Health Care (ACHC). Mr. Freeman has decades of laboratory compliance and managerial experience running high complexity military and private pathology laboratory organizations.

Mr. Freeman holds educational degrees in Healthcare Management, Histotechnology and Logistical Management. He received his formal Histopathology Laboratory training at the former Armed Forces Institute of Pathology’s (AFIP) Tri-Service School of Histotechnology, Washington, D. C.

Kim Futrell, MT(ASCP), MSHI

Kim Futrell is senior strategic marketing manager at Orchard Software where she is a contributing author for numerous laboratory-related magazines and Orchard’s white papers series which educates laboratorians on current industry topics and highlights the value and importance of the laboratory.

Prior to joining Orchard Software, Ms. Futrell worked as operations manager for a multi-specialty physician’s group after more than 20 years as a Laboratory Manager,

Milly Keeler, BSMT (ASCP), CLC (AMT), CCCP®

Milly Keeler is a CLIA Specialist with DoctorsManagement and serves as a Laboratory Technical Consultant for the company’s clients and her own through Keeler Laboratory Consulting, LLC.  Ms. Keeler’s more than 25 years of experience in multiple disciplines of laboratory testing in a variety of settings including hospitals, physician offices, urgent care facilities, and food service microbiology laboratories.

Ms. Keeper is passionate about the contribution of laboratory testing to quality patient outcomes. She has provided CLIA training for clients and professional organizations. Using her technical and operational expertise she specializes in working with laboratories to help them establish and perform laboratory testing that enhances the quality of patient care.

Diana L. Kremitske, MHA, MS, MT (ASCP)

Diana Kremitske is vice president of the Diagnostic Medicine Institute at Geisinger, overseeing laboratory and radiology operations and system courier services at eight hospital campuses and numerous clinics. She also participates in overseeing Geisinger’s Patient Blood Management Program.

Ms. Kremitske has experience in laboratory quality, with part of her career as Laboratory Service Improvement Coordinator and contributor to the early development of a laboratory error reporting mechanism and database. Recently she directed laboratory integration activities and process standardization efforts in hospital laboratory acquisitions and is involved in appropriate test utilization efforts.

Florent Letronne, PhD

Florent Letronne is laboratory science director of the Tartan Testing Lab at Carnegie Mellon University. The Tartan Testing Lab has now successfully achieved more than 130,000 PCR tests from asymptomatic CMU patients.

Before joining Carnegie Mellon, Dr. Letronne’s research was focused on the genetic and epigenetic determinants and risk factors of dementia and aging-related diseases with a particular interest in the genetic, cellular, and molecular mechanisms of neurodegeneration in Alzheimer’s disease and in traumatic brain injuries. Dr. Letronne is the  author of multiple articles in neuroscience publications including Molecular Psychiatry and EBioMedicine.

Jeanne Mumford, MT(ASCP)

Jeanne Mumford is pathology manager for point-of-care testing for Johns Hopkins Medicine.  Ms. Mumford’s years of experience include POCT-related regulatory oversight, quality assurance projects, and laboratory inspection preparedness and planning.

Her team of point of care coordinators work closely with providers across the enterprise to support patients’ needs by engaging, educating, and evaluating clinical testing personnel.  Her current role includes standardization of policies, procedures, instrumentation, and processes for the Point-of-Care Testing Program across three academic hospitals, three community hospitals and more than 60 ambulatory physician offices.

Catherine Otto, PhD, MBA, MLS(ASCP)cm

Catherine Otto is a professor at Rutgers University where she serves as program director of the Master of Science in Clinical Laboratory Science in the Department of Clinical Laboratory and Medical Imaging Sciences. She teaches undergraduate and graduate courses in hematology and laboratory management, among others. Her research interests include methods to improve patient safety and quality of laboratory services, and analyzing educational methods to incorporate patient safety competencies into MLS and MLT curricula.

Elissa Passiment, Ed.M., MT(ASCP)

Elissa Passiment is an adjunct assistant professor at Rutgers University School of Health Professions and the Executive Vice President Emeritus of the American Society for Clinical Laboratory Science (ASCLS).  She is a clinical laboratory scientist with over 20 years’ experience as staff, educator, and manager in clinical laboratories and 28 years in hospital consulting, health policy, and association management.

Ms. Passiment has served on the congressionally-mandated Negotiated Rulemaking Committee convened to standardize and simplify reimbursement for laboratory services; presented testimony to Institute of Medicine studies, and represented ASCLS at meetings with the FDA, CMS, and CDC.  She served as a member and the chair of the Clinical Laboratory Improvement Advisory Committee (CLIAC) with oversight of CLIA from 2007 – 2011.

Irwin Rothenberg, MBA, MS, CLS(ASCP)

Irwin Rothenberg is a freelance technical/content writer, providing articles and blogs for healthcare organizations and websites. He began working as a surveyor for COLA in 1996, a role in which he surveyed hundreds of clinical laboratories ranging in size from small physician office labs to those serving large hospital complexes.

Mr. Rothenberg was most recently a Technical Writer with COLA Resources, Inc., (CRI). He was involved as a Quality Advisor and participated in the development of the IQCP platform.

Reynolds M Salerno, PhD

Ren Salerno is the director of the Division of Laboratory Systems in the Center for Surveillance, Epidemiology, and Laboratory Services at the Centers for Disease Control and Prevention (CDC). He is the lead CDC official for the federal tri-agency Clinical Laboratory Improvement Amendments (CLIA) program and the Designated Federal Official of the US Clinical Laboratory Improvement Advisory Committee (CLIAC).

Dr. Salerno served as lead of CDC’s Expansion of Screening and Diagnostics Task Force for the COVID-19 Response and co-lead of the Laboratory and Testing Task Force for the COVID-19 Response. He has been responsible for developing much of CDC’s guidance for SARS-CoV-2 point-of-care and self-testing.